Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
This Bitcoin-first microcap is using its balance sheet to accumulate BTC (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Humacyte Inc HUMA

Alternate Symbol(s):  HUMAW

Financial Services Healthcare Biotechnology
Humacyte, Inc., together with its subsidiaries, engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs) to... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:HUMA)

Humacyte Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Humacyte, Inc. - HUMA

Business Wire 2 days ago

Humacyte Announces Fourth Quarter and Year End 2025 Financial Results and Provides Business Update

GlobeNewswire March 27, 2026

Humacyte Appoints Rick McElheny as Senior Vice President of Business Development

GlobeNewswire March 26, 2026

Humacyte To Announce 2025 Fourth Quarter and Year End Financial Results and Provide Business Update on March 27, 2026

GlobeNewswire March 23, 2026

Humacyte Receives Symvess® Purchase Commitment for Clinical Evaluation and Outreach Program in the Kingdom of Saudi Arabia

GlobeNewswire March 19, 2026

Humacyte, Inc. Announces Pricing of $20 Million Registered Direct Offering of Common Stock

GlobeNewswire March 19, 2026

Humacyte Submits Marketing Authorization Application for Symvess® in Israel for Vascular Trauma Repair

GlobeNewswire March 17, 2026

Humacyte To Participate in Upcoming Investor Conferences

GlobeNewswire March 2, 2026

Humacyte Announces Presentation of Symvess® Long-Term Safety and Efficacy Results at VESS Meeting

GlobeNewswire February 18, 2026
View More News ››

Opinion & Analysis (NDAQ:HUMA)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:HUMA)

Sell buddy sell.

Otherwise you guys will be going down big-time today and tomorrow
coolfooldumbguy - March 26, 2025
View more Bullboard ››

Calima Energy Ltd (EM)

Calima Energy Ltd (EM)

Calima Energy Limited invests in oil and gas exploration and production projects in Canada and internationally. The company ...
View More »

Podcasts